Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine
Figure 5
(a) RMSD, (b) SAS, (c) MSD, and (d) Gyrate for wenyujinoside, 28-deglucosylchikusetsusaponin IV, GLP1 corresponding protein, and GLP1 receptor protein alone (apo).
